JMP Group Announces Addition of Michael King as Equity Research Analyst
21 Dezember 2012 - 3:00PM
Business Wire
JMP Group Inc. (NYSE: JMP), an investment banking and
alternative asset management firm, announced today that Michael G.
King, Jr. has joined JMP Securities as a senior equity
research analyst. Mr. King, a managing director, follows the
biotechnology industry. He is based in the firm’s New York
office.
“JMP Securities has one of the top life sciences franchises on
Wall Street,” said Mark Lehmann, president of JMP Securities.
“Mike’s arrival signifies JMP’s dedication to further expanding
that platform in order to provide ever greater value to the firm’s
institutional customers and corporate clients in this highly
complex space. Mike is a seasoned analyst with a proven ability to
generate differentiated perspectives and actionable insights as a
result of a career that has included both accomplishments on the
sell-side and successes within the biotech industry. He is a key
addition in a key area for the firm.”
Prior to joining JMP Securities, Mr. King was a managing
director at Dawson James Securities, where he served as director of
research and as a senior biotechnology analyst. He was previously a
managing director and senior research analyst at Rodman &
Renshaw, a senior vice president and director of corporate
development at publicly traded ZIOPHARM Oncology, and a managing
director and senior equity analyst at Wedbush Securities.
Beforehand, Mr. King served as a managing director and senior
biotechnology analyst both at Merriman Curhan Ford and at Rodman
& Renshaw, where, in his initial tenure with the company, he
was also the director of research. Additionally, Mr. King has held
senior equity research positions at Banc of America Securities,
Robertson Stephens, Vector Securities and Dillon Read & Co.,
covering a wide range of market capitalizations and therapeutic
categories and earning recognition in analyst rankings produced by
The Wall Street Journal and Institutional Investor. Mr. King began
his career as a biotechnology specialist in the private client
sales divisions of Alex. Brown & Co., Hambrecht & Quist and
Kidder, Peabody & Co. He holds a BA in finance from The Bernard
M. Baruch College of the City University of New York.
About JMP Group
JMP Group Inc. is a full-service investment banking and asset
management firm that provides investment banking, sales and
trading, and equity research services to corporate and
institutional clients as well as alternative asset management
products to institutional and high-net-worth investors. JMP Group
operates through three subsidiaries: JMP Securities, Harvest
Capital Strategies and JMP Credit Advisors. For more information,
visit www.jmpg.com.
JMP (NYSE:JMP)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
JMP (NYSE:JMP)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über JMP Group LLC (New York Börse): 0 Nachrichtenartikel
Weitere JMP Group Inc. News-Artikel